Corey Young, Ph.D., M.S., joined the Integrative Tumor Epidemiology Branch (ITEB) as an iCURE postdoctoral fellow in December 2022, under the mentorship of Mitchell Machiela, Sc.D., Earl Stadtman investigator. Dr. Young received his B.S. and M.S. degrees in biology at North Carolina Agricultural and Technical State University, and received his Ph.D. in biomedical sciences in December 2022 at Morehouse School of Medicine, Atlanta, Georgia. His doctoral research focused on the use of prediction models, real world survey data, and early-stage biomarkers to reduce health disparities in lung cancer screening guidelines. He joined DCEG as an iCURE predoctoral fellow in the Biostatistics Branch (BB) in September 2020, where he studied the role of epidemiologic and molecular factors in lung cancer screening and progression. Dr. Young received a Scholar-in-Training Award from the American Association for Cancer Research in 2021.
In ITEB, Dr. Young's research is focused on investigating early-stage clonal chromosomal alterations in leukocytes and their potential relevance for hematological cancer risk.